Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Filgrastim × Breast × Clear all

Phase

Status

Completed 59 Terminated 9 Unknown 6 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 13 Lymphoid 6 Myeloid 5 CNS 5 Classical hematology 3 Sarcoma 2 Plasma cell 1 Dermatologic 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 65 Fulvestrant 63 Trastuzumab 53 Carboplatin 53 Letrozole 51 Capecitabine 51 Cyclophosphamide 49 Specimen Handling 47 Paclitaxel 45 Docetaxel 44 ribociclib 38 pertuzumab 37 abemaciclib 36 Magnetic Resonance Spectroscopy 33 trastuzumab deruxtecan 31 130-nm albumin-bound paclitaxel 28 sacituzumab govitecan 27 Biopsy 27 Anastrozole 27 Tamoxifen 26 Blood Specimen Collection 26 pyrotinib 24 Surveys and Questionnaires 23 exemestane 22 Radiotherapy 22 Injections 22 palbociclib 21 Epirubicin 21 Drug Therapy 21 Bevacizumab 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05753618 2026-02-09

REaCT-OGF

Ottawa Hospital Research Institute

Phase 4 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡